Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26176829)

Published in Kidney Int on July 15, 2015

Authors

Marc Lúcia1, Sergi Luque1, Elena Crespo1, Edoardo Melilli2, Josep M Cruzado1,2, Jaume Martorell3, Marta Jarque1, Salvador Gil-Vernet2, Anna Manonelles2, Josep M Grinyó1,2, Oriol Bestard1,2

Author Affiliations

1: Experimental Nephrology Laboratory, IDIBELL, Barcelona, Spain.
2: Renal Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona University, Barcelona, Spain.
3: Histocompatibility Unit, Immunology Department, Hospital Clinic, Barcelona, Spain.

Associated clinical trials:

The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation (COMBAT) | NCT05145296

Articles cited by this

CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24

Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31

Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med (2007) 6.13

Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol (2003) 5.51

Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet (2012) 4.85

Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods (2004) 4.57

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol (2010) 2.66

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol (2007) 2.64

Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation (2010) 2.59

Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation (2009) 2.28

B cell memory and the long-lived plasma cell. Curr Opin Immunol (1999) 2.03

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev (2010) 1.99

Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol (2009) 1.74

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine (1996) 1.72

Diversity among memory B cells: origin, consequences, and utility. Science (2013) 1.65

Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant (2004) 1.54

Diagnosis and prevention of chronic kidney allograft loss. Lancet (2011) 1.52

Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine (2005) 1.51

Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50

Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome. Am J Transplant (2013) 1.47

Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol (2005) 1.36

Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol (2001) 1.26

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses. J Immunol Methods (2013) 1.12

Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant (2006) 1.09

Antibody-mediated rejection in renal allografts: lessons from pathology. Clin J Am Soc Nephrol (2006) 1.09

Long-term presence of memory B-cells specific for different vaccine components. Vaccine (2009) 1.09

Enzyme-linked immunoassay for anti-HLA antibodies--an alternative to panel studies by lymphocytotoxicity. Transplantation (1993) 0.99

HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation (2007) 0.99

HLA-specific B cells: II. Application to transplantation. Transplantation (2007) 0.97

Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells. Clin Exp Immunol (2014) 0.97

The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96

An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body. J Immunol Methods (2010) 0.96

Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers. J Immunol (2003) 0.95

Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant (2008) 0.93

Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients. Clin Infect Dis (2014) 0.87

A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals. Am J Transplant (2012) 0.85

Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay. Transplantation (2009) 0.85

Peripheral blood B cells producing donor-specific HLA antibodies in vitro. Hum Immunol (2008) 0.82

Characterization of anti-HLA antibodies eluted from explanted renal allografts. Clin Transpl (2006) 0.82

Memory B cells in transplantation. Transplantation (2015) 0.82

Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study. Hum Immunol (1995) 0.80

The flow cytometric detection of alloantibodies in screening for renal transplantation. Transpl Int (1995) 0.79

Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant. Kidney Int (2015) 0.78

Quantification of HLA class II-specific memory B cells in HLA-sensitized individuals. Hum Immunol (2015) 0.78